Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication July 6, 2011
- Accepted for publication January 3, 2012
- Published online May 1, 2012.
Article Versions
- previous version (April 10, 2012 - 05:13).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2012 by the Society of Nuclear Medicine, Inc.
Author Information
- Adrianus J. de Langen1,
- Andrew Vincent2,
- Linda M. Velasquez3,
- Harm van Tinteren2,
- Ronald Boellaard4,
- Lalitha K. Shankar5,
- Maarten Boers6,
- Egbert F. Smit1,
- Sigrid Stroobants7,
- Wolfgang A. Weber8 and
- Otto S. Hoekstra4
- 1Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands
- 2Department of Biostatistics, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
- 3Bristol-Myers Squibb Co., Princeton, New Jersey
- 4Department of Nuclear Medicine and PET Research, VU University Medical Center, Amsterdam, The Netherlands
- 5Cancer Imaging Program, National Cancer Institute, Bethesda, Maryland
- 6Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands
- 7Department of Nuclear Medicine, University Hospital Antwerpen, Antwerpen, Belgium; and
- 8Nuklearmedizinische Klinik, Universitätsklinikum Freiburg, Freiburg, Germany
- For correspondence or reprints contact: Adrianus J. de Langen, Department of Pulmonary Diseases, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands. E-mail: j.delangen{at}vumc.nl
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2--Technical)
- Investigating Low-Dose Image Quality in Whole-Body Pediatric 18F-FDG Scans Using Time-of-Flight PET/MRI
- Performance of Digital PET Compared with High-Resolution Conventional PET in Patients with Cancer
- Positive Predictive Value of Neck Imaging Reporting and Data System Categories 3 and 4 Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma
- Prognostic value of 18F-FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project
- Metabolic Biomarker-Based BRAFV600 Mutation Association and Prediction in Melanoma
- Test-Retest Reproducibility of 18F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network
- Negative Predictive Value of NI-RADS Category 2 in the First Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma
- Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer
- Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy
- Semiquantitative Parameters in PSMA-Targeted PET Imaging with 18F-DCFPyL: Variability in Normal-Organ Uptake
- Repeatability of SUV in Oncologic 18F-FDG PET
- PET/CT in nononcological lung diseases: current applications and future perspectives
- Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance
- Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients
- Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer
- Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials
- Quantitative Positron Emission Tomography Imaging for Response Assessment of [18F]Fluorodeoxyglucose-Avid Lymphomas: Should We Report Standard Uptake Value Confidence Limits?
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
- Repeatability of Quantitative FDG-PET/CT and Contrast-Enhanced CT in Recurrent Ovarian Carcinoma: Test-Retest Measurements for Tumor FDG Uptake, Diameter, and Volume
- Variability of Total Lesion Glycolysis by 18F-FDG-Positive Tissue Thresholding in Lung Cancer